Emerging Company Profile
Synthekine launches with $82M to create new cytokine signals
Modality-agnostic newco gives cytokines the GPCR treatment for cancer and autoimmunity
Stanford spinout taps structural biology from Chris Garcia’s lab to get new functions from natural cytokine receptors.
Synthekine is translating the structural biology work of Stanford synthetic cytokine pioneer K. Chris Garcia into a broad platform that could generate